SAN FRANCISCO--(BUSINESS WIRE)--McKesson Corporation (NYSE:MCK) today announced that Brian S. Tyler, Ph.D., has been appointed president and chief operating officer, McKesson Corporation, effective August 2, 2018. Tyler will report to John Hammergren, chairman and chief executive officer, and will become a member of the executive committee.
“Brian is ideally suited to lead McKesson’s global operations based on his deep industry knowledge, outstanding track record as a business leader, and his commitment to operational excellence and customer success,” said Hammergren. “His broad experience as the president of multiple McKesson businesses provides him with the ideal background and perspective to help lead McKesson’s strategic initiative and drive long-term growth.”
Previously Chairman of the Management Board, McKesson Europe, Tyler has also served as president of McKesson North American Pharmaceutical Distribution and Services, McKesson U.S. Pharmaceutical, McKesson Medical-Surgical and McKesson Specialty Health, as well as executive vice president of corporate strategy and business development.
Ad Statistics
Times Displayed: 2130
Times Visited: 4 Stay up to date with the latest training to fix, troubleshoot, and maintain your critical care devices. GE HealthCare offers multiple training formats to empower teams and expand knowledge, saving you time and money.
His direct reports will include:
President, Transformation Initiatives
Chairman, Management Board, McKesson Europe
President, McKesson U.S. Pharmaceutical and Specialty Health
President, McKesson Medical-Surgical
CEO, McKesson Canada
President, McKesson Prescription Technology Solutions (MRxTS)
President, Transformation Initiatives
Chairman, Management Board, McKesson Europe
“McKesson has outstanding products, services and solutions, and world class talent,” said Tyler. “With these assets, the company is uniquely positioned to drive innovation across the healthcare supply chain that will improve value for our business partners and enable better, more cost-effective patient care. I look forward to working with our customers, manufacturing partners and McKesson’s more than 78,000 associates to deliver on that potential and accelerate McKesson’s growth.”
Tyler earned his Ph.D. and M.A. from the University of Chicago, Department of Economics in 1994, where he studied under a grant from the National Science Foundation, and earned his B.A. in economics with high honors from University of California Santa Cruz in 1989.
McKesson also announced today that Nick Loporcaro, president of McKesson’s U.S. Pharmaceutical and Specialty Solutions segment, has decided to leave McKesson to pursue other opportunities. Upon Loporcaro’s departure on August 10, Tyler will lead this segment directly until Loporcaro’s replacement has been named.
